According to Precision BioSciences 's latest financial reports and stock price the company's current Operating Margin is -440.37%. At the end of 2021 the company had an Operating Margin of -26.49%.
Year | Operating Margin | Change |
---|---|---|
2021 | -26.49% | -94.1% |
2020 | -448.86% | 7.47% |
2019 | -417.65% | -1.27% |
2018 | -423.02% | 29.98% |
2017 | -325.45% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 0.00% | N/A | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.